Mid Cap and Large Cap Watch List member IMS Health (RX) delivered 14% revenue and 15% operating income growth in the first quarter: IMS Health, the world’s leading provider of market intelligence to ...
NORWALK, Conn.--(BUSINESS WIRE)--Global prescription sales growth of generics drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback